Open AccessPrognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis
Author(s) -
Keiichi Sumida,
Miklos Z. Molnar,
Praveen K. Potukuchi,
Fridtjof Thomas,
Jun Lü,
Yoshitsugu Obi,
Connie M. Rhee,
Elani Streja,
Kunihiro Yamagata,
Kamyar KalantarZadeh,
Csaba P. Kövesdy
Publication year - 2016
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfw412
Subject(s) - medicine , dialysis , kidney disease , end stage renal disease , interquartile range , hazard ratio , renal function , gastroenterology , quartile , hemodialysis , peritoneal dialysis , confidence interval , endocrinology
Higher serum alkaline phosphatase (ALP) levels have been associated with excess mortality in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and end-stage renal disease (ESRD). However, little is known about the impact of late-stage NDD-CKD ALP levels on outcomes after dialysis initiation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom